Study guide
8.1 Approach to the Poisoned Patient: Poison Centers, Toxidromes, Decontamination & Enhanced Elimination
BCEMP Board Certified Emergency Medicine Pharmacist Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction, Triage, and Resuscitation Fundamentals
1.1 BCEMP Exam Logistics, Content Outlines & Scoring 1.2 Emergency Triage Systems (ESI) & Pre-Hospital Care Coordination 1.3 Resuscitation Pharmacology, Pharmacokinetics & Vascular Access
2 Chapter 2: Cardiac Arrest and Dysrhythmias
2.1 Adult Cardiac Arrest & ACLS Pharmacotherapy Protocols 2.2 Acute Tachyarrhythmias: Narrow- and Wide-Complex Management 2.3 Symptomatic Bradycardia & Vasoactive Chronotropic Support 2.4 Post-Cardiac Arrest Care & Targeted Temperature Management (TTM)
3 Chapter 3: Shock and Hemodynamic Resuscitation
3.1 Sepsis & Septic Shock: Surviving Sepsis Campaign 2026 Resuscitation 3.2 Cardiogenic & Obstructive Shock, Mechanical Circulatory Support & LVADs 3.3 Hypovolemic & Hemorrhagic Shock Fluid Protocols
4 Chapter 4: Airway Management and Rapid Sequence Intubation (RSI)
4.1 Rapid Sequence Intubation (RSI) Process & Pretreatment Agents 4.2 RSI Induction Agents: Pharmacology, Selection & Dosing 4.3 Neuromuscular Blocking Agents & Post-Intubation Analgosedation
5 Chapter 5: Neurocritical Care and Neurologic Emergencies
5.1 Acute Ischemic Stroke: Thrombolysis & Blood Pressure Control 5.2 Intracranial Hemorrhage & Elevated ICP Pharmacotherapy 5.3 Status Epilepticus: Tiered Emergent Anticonvulsant Therapy 5.4 Traumatic Brain Injury & Spinal Cord Emergencies
6 Chapter 6: Acute Coronary Syndromes and Acute Heart Failure
6.1 Acute Coronary Syndromes: STEMI & NSTE-ACS Pharmacotherapy 6.2 Acute Decompensated Heart Failure & Cardiogenic Pulmonary Edema 6.3 Hypertensive Crises: Emergencies, Urgencies & Target Blood Pressure
7 Chapter 7: Pulmonary and Allergic Emergencies
7.1 Acute Pulmonary Embolism: Risk Stratification & Thrombolytic Therapy 7.2 Severe Asthma Exacerbation & COPD Acute Management 7.3 Anaphylaxis & Severe Allergic Reactions: Acute Epinephrine Protocols
8 Chapter 8: Clinical Toxicology: Approach to Poisoning and Common Overdoses
8.1 Approach to the Poisoned Patient: Poison Centers, Toxidromes, Decontamination & Enhanced Elimination 8.2 Acetaminophen Overdose & N-Acetylcysteine Dosing Strategies 8.3 Salicylate Toxicity & Toxic Alcohol Management (Fomepizole) 8.4 Opioid Toxicity & Sedative-Hypnotic/Alcohol Withdrawal Syndromes 8.5 Beta-Blocker & Calcium Channel Blocker Toxicity (HIET, Calcium, Glucagon)
9 Chapter 9: Toxicology: Specialized Poisonings and Antidotes
9.1 Digoxin, Tricyclic Antidepressants & Anticholinergic Toxicity 9.2 Cyanide, Carbon Monoxide & Organophosphate/Cholinergic Toxins 9.3 Snake and Spider Envenomations & Heavy Metal Chelation 9.4 Additional Antidotes: Methemoglobinemia, Isoniazid, Sulfonylureas, Valproate, Sympathomimetics & LAST
10 Chapter 10: Hemostasis, Anticoagulant Reversal, and Hematology
10.1 DOAC & Warfarin Reversal: Specific Reversal Agents & 4F-PCC 10.2 Heparin-Induced Thrombocytopenia (HIT) & Direct Thrombin Inhibitors 10.3 Sickle Cell Vaso-Occlusive Crises & Acute Chest Syndrome
11 Chapter 11: Endocrine, Electrolyte, and Metabolic Emergencies
11.1 Diabetic Ketoacidosis (DKA) & Hyperosmolar Hyperglycemic State (HHS) 11.2 Severe Electrolyte Emergencies: Hyperkalemia & Hyponatremia 11.3 Endocrine Crises: Thyroid Storm, Myxedema Coma & Acute Adrenal Crisis 11.4 Acute Kidney Injury, Dialyzability & Drug Dosing during RRT
12 Chapter 12: Infectious Diseases and Antimicrobial Stewardship
12.1 Severe Community & Hospital-Acquired Infections in the ED 12.2 Skin & Soft Tissue, STI, and Vector-Borne Emergencies 12.3 ED Antimicrobial Stewardship & Rapid Microbiologic Diagnostics
13 Chapter 13: Special Populations: Pediatrics, Trauma, and Obstetrics
13.1 Pediatric Resuscitation, Status Epilepticus & PALS Pharmacotherapy 13.2 Trauma Pharmacotherapy: Massive Transfusion, TXA, Open Fractures, Tetanus & Burns 13.3 Obstetric & Gynecologic Emergencies: Preeclampsia, Eclampsia & PPH
14 Chapter 14: Medication Safety, ED Operations, and Disaster Preparedness
14.1 ED High-Alert Medications, Error Reporting & Technology Safeguards 14.2 ED Workflow, Transitions of Care & Boarding Patient Management 14.3 Mass Casualty Incidents, CBRNE Countermeasures & Strategic Stockpiles
15 Chapter 15: Biostatistics, Study Design, and Literature Evaluation
15.1 Biostatistics & Hypothesis Testing: Power, Errors & Interpretations 15.2 Clinical Study Designs & Measures of Effect 15.3 Literature Evaluation, Clinical Guidelines & Research Conduct in the ED
16 Chapter 16: Medical Devices, Ventilation, and Medication Delivery
16.1 Mechanical Ventilation, Noninvasive Ventilation & High-Flow Oxygen: What the Pharmacist Must Know 16.2 Vascular Access, Enteral Tubes, Drains & Extravasation Management 16.3 Infusion Pumps, Patient-Owned Devices & Medication Delivery Device Counseling
17 Chapter 17: Organ-System Emergencies: GI, GU, Oncology, Neurology, ENT, Pain, and Psychiatry
17.1 Gastrointestinal & Hepatic Emergencies: GI Bleeding, Cirrhosis Complications, Pancreatitis & Vomiting 17.2 Genitourinary Emergencies: UTI & Pyelonephritis, Renal Colic, Urinary Retention, Priapism & Scrotal Infections 17.3 Oncologic, Immunotherapy & Hematologic Emergencies: Febrile Neutropenia, TLS, Hypercalcemia, irAEs, CAR-T, Hemophilia & TTP 17.4 Headache & Neuromuscular Emergencies: Migraine, Cluster, Myasthenic Crisis, Guillain-Barré & Bell's Palsy 17.5 Ophthalmologic, ENT & Dental Emergencies: Eye Injuries, Angle Closure, Angioedema, Epistaxis, Ear & Throat Infections and Dental Pain 17.6 Acute Pain Management & Procedural Sedation and Analgesia in the ED 17.7 Psychiatric Emergencies: Severe Agitation, Serotonin Syndrome, NMS, Lithium Toxicity & Psychotropic Overdose
18 Chapter 18: Special Populations, Medication Access, and Professional Practice
18.1 Pharmacogenomics, Adverse Drug Events & High-Risk Drug Interactions in Emergency Care 18.2 Special Populations: Older Adults, Extremes of Weight, Pregnancy & Lactation, and Immunocompromised Patients 18.3 Social Determinants of Health, Health Literacy & Medication Access at ED Discharge 18.4 Healthcare Regulations & Standards: FDA, REMS, Bar Coding, DEA, CMS, EMTALA, The Joint Commission, NIOSH & USP 18.5 Formulary & Inventory Management, Drug Shortages, Antidote Stocking & Clinical Decision Support 18.6 Quality Improvement, Practice Standards & Interprofessional Collaboration (Protocols, Teamwork & Debriefing)
8.1 Approach to the Poisoned Patient: Poison Centers, Toxidromes, Decontamination & Enhanced Elimination
Key Takeaways Explain This Topic AI
In 2024, 55 US poison centers managed nearly 2.1 million human exposures through the single Poison Help line, 1-800-222-1222 (America's Poison Centers NPDS report).
Every intentional ingestion needs a glucose, ECG, acetaminophen and salicylate concentrations, and a basic metabolic panel, because co-ingestants are common and early signs are often absent.
Single-dose activated charcoal (1 g/kg, usually 50 g in adults) is most useful within about 1 hour and is withheld when the airway is unprotected or the agent binds poorly.
Whole bowel irrigation with polyethylene glycol electrolyte solution is reserved for sustained-release products, iron, lithium and drug packets, at 1.5 to 2 L/h in adults.
Extracorporeal removal works best for small, water-soluble, poorly protein-bound drugs with a low volume of distribution, such as lithium, salicylates, toxic alcohols, metformin and valproate.
Last updated: October 2026
8.1 Approach to the Poisoned Patient: Poison Centers, Toxidromes, Decontamination & Enhanced Elimination
Note
Exam scope: 2025 outline subtopics 1A4 (Toxicology / Poison Centers) and 2B13 (Pharmacotherapy for Toxicology). On the 2024 outline this maps to tasks on differential diagnosis, outside resources and time-sensitive therapy. Agent-specific antidotes follow in Sections 8.2 to 9.4.
Poison Centers and the Emergency Medicine Pharmacist
The United States has a single national Poison Help line, 1-800-222-1222 , which routes callers to their regional center. According to the 2024 National Poison Data System (NPDS) report from America's Poison Centers, 55 US poison centers handled nearly 2.1 million human exposures that year, about one every 15 seconds. Most calls from homes are managed without an ED visit, and that triage is a large part of the network's value.
Poison centers are staffed by specialists in poison information, many of them pharmacists or nurses, with medical toxicologists on call. Calls from hospitals feed NPDS, the near real-time surveillance system that detects outbreaks of adulterated drugs, new psychoactive substances and product hazards.
Consult the poison center (or the institution's toxicology service) for:
Every intentional or unknown ingestion, especially with sustained-release products or multiple agents.
Unfamiliar substances: plants, mushrooms, household chemicals, veterinary drugs, foreign products.
Antidote decisions with narrow indications, such as digoxin immune fab, physostigmine, high-dose insulin, lipid emulsion or antivenom.
Decisions about decontamination and extracorporeal removal.
The emergency medicine pharmacist adds four practical contributions at the bedside:
Product identification : imprint codes, formulation (immediate- vs. extended-release), salt form and concentration of liquids.
Worst-case dose estimation : assume every missing tablet was taken and convert to mg/kg.
Antidote logistics : locating stock, calculating doses and preparing infusions (stocking standards appear in Section 18.5).
Timeline building : time of ingestion drives nomogram use, observation periods and decontamination decisions.
Structured Initial Assessment
Stabilize the airway, breathing and circulation first. Check a point-of-care glucose in every patient with altered mental status. Give naloxone in titrated doses for suspected opioid toxicity with respiratory depression (Section 8.4). Thiamine should never delay dextrose in a hypoglycemic patient.
The history covers five questions: what (agent and formulation), how much , when , by what route , and why (intentional, accidental or recreational). Ask about every medication in the home, not only the patient's own.
Screening Tests After an Intentional Ingestion
Test Reason
Acetaminophen concentration Early acetaminophen toxicity has no reliable signs, and NAC is most effective when started within 8 hours
- Salicylate concentration Mixed acid-base disorders and delayed peaks with enteric-coated products
- ECG QRS widening (sodium channel blockade), QTc prolongation, heart block, ischemia
Basic metabolic panel and anion gap Anion gap = Na − (Cl + HCO3); elevated in toxic alcohol, salicylate, metformin, iron and cyanide poisoning
Serum osmolality Osmolar gap = measured − calculated (2 Na + glucose/18 + BUN/2.8); a normal gap does not exclude a late toxic-alcohol presentation
- Pregnancy test Changes antidote and imaging choices
- CK, lactate, venous blood gas Rhabdomyolysis, hypoperfusion and acid-base status
- Limits of Urine Drug Screens
Immunoassay urine drug screens rarely change emergency management and often mislead:
Fentanyl and its analogues are not detected by the standard opiate immunoassay, which targets morphine and codeine. Methadone, buprenorphine and often oxycodone also need separate assays.
Benzodiazepine screens frequently miss clonazepam and lorazepam.
Amphetamine screens can be falsely positive with bupropion, labetalol, pseudoephedrine and other drugs.
A positive result shows exposure in the past days, not intoxication now.
Toxidrome Recognition
A toxidrome is a cluster of signs that points to a drug class before results return. Skin moisture and pupil size separate the most commonly confused patterns.
Toxidrome Vital signs Pupils Skin Other key findings Examples
Sympathomimetic High HR, BP, temperature Dilated Diaphoretic Agitation, seizures, tremor Cocaine, amphetamines, synthetic cathinones
Anticholinergic High HR, temperature Dilated Dry, flushed Delirium, urinary retention, absent bowel sounds Diphenhydramine, tricyclics, jimsonweed
Cholinergic Low or high HR, bronchorrhea Constricted Wet Salivation, lacrimation, urination, diarrhea, fasciculations Organophosphates, carbamates, nerve agents
Opioid Low RR, low HR Constricted Normal Coma, decreased bowel sounds Heroin, fentanyl, methadone
Sedative-hypnotic Often near normal Normal Normal Coma with preserved vital signs, ataxia Benzodiazepines, barbiturates, Z-drugs
Serotonin toxicity High HR, temperature Dilated Diaphoretic Clonus and hyperreflexia, more in the legs SSRIs with MAOIs, linezolid, tramadol
Sedative or alcohol withdrawal High HR, BP, temperature Dilated Diaphoretic Tremor, hallucinations, seizures Ethanol, benzodiazepines, baclofen
Tip
Sympathomimetic and anticholinergic toxicity look alike at the door. Feel the axilla: sweat favors a sympathomimetic, while dry skin with urinary retention favors an anticholinergic. Clonus points to serotonin toxicity (Section 17.7).
Gastrointestinal Decontamination
Decontamination is a risk-benefit decision for each patient, not a routine step. Position statements from the American Academy of Clinical Toxicology (AACT) and the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) shape current practice.
Single-Dose Activated Charcoal
Dose: 1 g/kg orally or by tube; adults usually receive 50 g.
Timing: benefit is most likely within about 1 hour of ingestion. Later use is reasonable for delayed absorption, such as with sustained-release or anticholinergic products.
Withhold when: the airway is unprotected or mental status is declining (aspiration risk), there is bowel obstruction or perforation, or the ingestion is a caustic or hydrocarbon.
Binds poorly: metals such as iron and lithium, alcohols and glycols, hydrocarbons, acids and alkalis.
Avoid cathartics: sorbitol adds no proven benefit, and repeated doses can cause dehydration and hypernatremia, especially in children.
Multiple-Dose Activated Charcoal (MDAC)
MDAC interrupts enterohepatic and enteroenteric recirculation, sometimes called "gut dialysis." The 1999 AACT/EAPCCT position statement supports it for life-threatening ingestions of carbamazepine, dapsone, phenobarbital, quinine and theophylline . After the initial dose, adults commonly receive about 25 g every 2 hours or 50 g every 4 hours. Bowel sounds must be present, and an antiemetic improves tolerance.
Whole Bowel Irrigation (WBI)
WBI pushes unabsorbed drug through the gut with polyethylene glycol electrolyte solution (PEG-ELS) by nasogastric tube until the rectal effluent is clear:
- Age PEG-ELS rate
- 9 months to 6 years 500 mL/h
- 6 to 12 years 1,000 mL/h
- Adolescents and adults 1,500 to 2,000 mL/h
Indications are sustained-release or enteric-coated products, iron, lithium, and packets of illicit drugs (body packers). Contraindications include ileus, obstruction or perforation, GI bleeding, an unprotected airway, hemodynamic instability and intractable vomiting. A ruptured cocaine packet with severe toxicity needs surgery, not more irrigation.
Gastric Lavage and Ipecac
Gastric lavage should not be used routinely. It risks aspiration, esophageal injury and hypoxia and has not been shown to improve outcomes. Syrup of ipecac has no role: the American Academy of Pediatrics advised against keeping it at home in 2003.
- Enhanced Elimination
- Urinary Alkalinization
Raising urine pH traps weak acids in the tubular lumen. The main indication is salicylate poisoning; others include chlorpropamide, methotrexate and chlorophenoxy herbicides. Aim for urine pH 7.5 to 8.0 while keeping serum pH no higher than about 7.55 and replacing potassium, because hypokalemia blocks urine alkalinization (Section 8.3).
Extracorporeal Treatment (ECTR)
The EXTRIP workgroup publishes poison-specific recommendations. Drugs are good candidates when they are:
Small (below about 500 Da for conventional dialysis; high-flux membranes clear larger molecules).
Water-soluble with a low volume of distribution (below about 1 L/kg).
Poorly protein-bound , or saturating their binding sites at toxic concentrations, as salicylate and valproate do.
Slowly cleared by the body.
Classic candidates include lithium, salicylates, methanol and ethylene glycol, metformin-associated lactic acidosis, valproate, carbamazepine, phenobarbital and theophylline . Intermittent hemodialysis gives the fastest clearance; continuous therapy is a fallback when the patient cannot tolerate it. Digoxin and tricyclic antidepressants are not removed meaningfully because of high tissue binding. Section 11.4 covers drug dialyzability in more detail.
Observation and Disposition
Situation Usual minimum approach
Asymptomatic after an immediate-release ingestion with a normal workup About 4 to 6 hours of observation, then medical clearance
- Sustained-release calcium channel or beta blockers Extended monitoring, commonly 24 hours
- Sulfonylureas Overnight or longer glucose monitoring (Section 9.4)
- Methadone or buprenorphine in a young child Admission with continuous pulse oximetry
- Toxic alcohols Until the acidosis and osmolar gap resolve or levels are confirmed safe
- Drug packets Until all packets have passed and imaging is clear
Some products can seriously harm a toddler after one or two tablets or a small swallow : opioids including buprenorphine, sulfonylureas, calcium channel blockers, tricyclic antidepressants, clonidine, methyl salicylate (oil of wintergreen), camphor and diphenoxylate-atropine. Treat any reported pediatric exposure to these agents as potentially serious.
After an intentional overdose, medical clearance is followed by a suicide risk assessment. The Joint Commission's 2026 National Performance Goals include a dedicated goal on reducing suicide risk.